The MJ BIOTECH, INC. (MJTV) corporate philosophy includes distribution programs that are sensitive to addressing patient populations with unmet medical needs, emphasizing many under-served or completely un-served populations.
Our first priority is educating the community about COVID-19 and how to detect it in people.
To learn more about COVID-19, please click the button below.
MJ BIOTECH, INC. (OTC: MJTV) is a publicly traded biopharmaceutical company. Our shares are traded on the Over The Counter markets. To obtain share information or financial information, please click this link:
We proudly announce that as of December 9, 2020, our kits are available for sale immediately. To learn more, please see our press release.
The most reliable indicator of prior exposure to COVID-19 infection is the antibody test. We now sell a rapid IgG/IgM immunoassay test system using a small blood sample to detect an active immune response to a current or prior COVID-19 infection.
Click here to learn more about our test kit and how to purchase it.
Our price includes two-way shipping and a Physician's Fee.
This product can only be used in Laboratories certified under the Clinical Laboratories Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a to perform moderate or high complexity tests.
Sign up to hear about our current products and our new products.